NCT03146013 - Dual Algorithm Post Market Clinical Study | Biotech Hunter

Enrollment

100

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions

HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1Human T-lymphotropic Virus 2HTLV I Associated T Cell Leukemia LymphomaHTLV I Associated Myelopathies

Interventions

DIAGNOSTIC_TEST

MP Diagnostics HTLV Blot 2.4

HTLV I/II Confirmation and Differentiation

Trial Locations (1)

28273

American Red Cross - National Testing Laboratory, Charlotte